- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01868672
Brief Intervention to Create Smoke-Free Homes Policies in Low-Income Households: North Carolina Effectiveness Trial
The burden of tobacco use falls disproportionately on low-income populations, through high rates of primary smoking and exposure to secondhand smoke. The remarkable progress in creating smoke-free environments in the U.S. over the past two decades has left smoker's homes as one of the primary sources of exposure to secondhand smoke for both children and nonsmoking adults. Intervention research that identifies effective and practical strategies for reaching the minority of households that still allow smoking in the home has considerable potential to reduce smoke exposure, but suitable channels to reach low-income families are limited.
The proposed research will systematically test an intervention designed to create smoke-free homes in low income households among 2-1-1 callers. During this randomized control trial, researchers will disseminate and evaluate a brief smoke-free homes intervention through the established infrastructure of a North Carolina 2-1-1 call center. 2-1-1 is a nationally designated 3-digit telephone exchange, similar to 9-1-1 for emergencies or 4-1-1 for directory assistance, that links callers to community-based health and social services. The main hypothesis to be tested is that a higher proportion of households in the intervention group will establish and maintain a smoke-free home than in the measures-only control group.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
North Carolina
-
Chapel Hill, North Carolina, United States, 27599
- University of North Carolina, Chapel Hill
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Must be 18 years of age or older.
- Must speak and understand English.
- Must smoke and live with at least one other non-smoking person OR be a non-smoker who lives with a smoker(s).
- Must not have a total smoking ban in their home.
Exclusion Criteria:
- All participants who are not in immediate crisis will be invited to participate in the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control
Participant receives usual care.
|
|
|
Experimental: Intervention
Educational print materials and coaching call: Intervention group participants receive three sets of mailed educational materials about making their home smoke-free and one coaching call.
|
Intervention group participants receive three sets of mailed educational materials about making their home smoke-free and one coaching call.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Presence of a total home smoking ban
Time Frame: Change from baseline in reported total home smoking bans at 3-month and 6-month follow-up
|
Change from baseline in reported total home smoking bans at 3-month and 6-month follow-up
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Cessation attempts (for smokers)
Time Frame: Change from baseline in reported cessation attempts (for smokers) at 3-month and 6-month follow-up
|
Change from baseline in reported cessation attempts (for smokers) at 3-month and 6-month follow-up
|
|
Number of cigarettes smoked (for smokers)
Time Frame: Change from baseline in reported number of cigarettes smoked (for smokers) at 3-month and 6-month follow-up
|
Change from baseline in reported number of cigarettes smoked (for smokers) at 3-month and 6-month follow-up
|
|
Stage of change to quit smoking (for smokers)
Time Frame: Change from baseline in stage of change to quit smoking (for smokers) at 3-month and 6-month follow-up
|
Change from baseline in stage of change to quit smoking (for smokers) at 3-month and 6-month follow-up
|
|
Successful cessation (for smokers)
Time Frame: Change from baseline in successful cessation (for smokers) at 3-month and 6-month follow-up
|
Change from baseline in successful cessation (for smokers) at 3-month and 6-month follow-up
|
|
Weekly secondhand smoke exposure for non-smokers
Time Frame: Change from baseline in reported secondhand smoke exposure fro non-smokers at 3-month and 6-month follow-up
|
Change from baseline in reported secondhand smoke exposure fro non-smokers at 3-month and 6-month follow-up
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Rebecca S Williams, MHS, PhD, University of North Carolina, Chapel Hill
Publications and helpful links
General Publications
- Kegler MC, Escoffery C, Bundy L, Berg CJ, Haardorfer R, Yembra D, Schauer G. Pilot study results from a brief intervention to create smoke-free homes. J Environ Public Health. 2012;2012:951426. doi: 10.1155/2012/951426. Epub 2012 May 17.
- Escoffery C, Bundy L, Carvalho M, Yembra D, Haardorfer R, Berg C, Kegler MC. Third-hand smoke as a potential intervention message for promoting smoke-free homes in low-income communities. Health Educ Res. 2013 Oct;28(5):923-30. doi: 10.1093/her/cyt056. Epub 2013 May 13.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-1808
- U01CA154282 (U.S. NIH Grant/Contract)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Chronic Disease
-
3-C Institute for Social DevelopmentUniversity of North Carolina, Chapel HillCompletedChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Pediatric Kidney Disease | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage V | Chronic Kidney Disease, Stage IV (Severe) | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease, Stage IUnited States
-
Universiti Putra MalaysiaRecruitingChronic Kidney Diseases | Chronic Kidney Disease Stage 5 | Chronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Requiring Chronic DialysisMalaysia
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsRecruitingChronic Disease | Chronic Conditions, Multiple | Chronic ConditionDenmark
-
Parker Research InstituteOak Foundation; Rehabilitation Center Rødovre Municipality (Genoptræning Rødovre... and other collaboratorsCompletedChronic Conditions, Multiple | Chronic ConditionDenmark
-
Radboud University Medical CenterRecruitingChronic Conditions, Multiple | Chronic ConditionNetherlands
-
Radboud University Medical CenterCompleted
-
University of LimerickCompletedChronic Conditions, MultipleIreland
-
University of LeicesterUniversity Hospitals, Leicester; University of StrathclydeRecruitingChronic Obstructive Pulmonary Disease (COPD) | Chronic Obstructive Lung Disease | Chronic Obstructive Airway DiseaseUnited Kingdom
-
National Taipei University of Nursing and Health...TerminatedChronic Pulmonary Disease | Chronic Obstructive Pulmonary Disease Exacerbation | Chronic Obstructive Pulmonary Disease With ExacerbationTaiwan
-
National Taiwan University HospitalCompletedChronic Kidney Disease stage4 | Chronic Kidney Disease stage3 | Chronic Kidney Disease Stage 2 | Chronic Kidney Disease Stage 1Taiwan
Clinical Trials on Educational print materials and coaching call
-
The University of Texas Health Science Center,...National Cancer Institute (NCI); Washington University School of Medicine; Emory... and other collaboratorsCompletedChronic DiseaseUnited States
-
Emory UniversityNational Cancer Institute (NCI); The University of Texas Health Science Center... and other collaboratorsCompletedChronic DiseasesUnited States
-
Dana-Farber Cancer InstituteNational Cancer Institute (NCI)Active, not recruitingSexual Function Disturbances | Cancer SurvivorshipUnited States
-
VA Office of Research and DevelopmentRecruitingSmoking Cessation | Veterans HealthUnited States
-
Albert Einstein College of MedicineNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); New...CompletedType 2 DiabetesUnited States
-
La Trobe UniversityRecruitingAnterior Cruciate Ligament Injuries | Concussion, Brain | Musculoskeletal InjuryAustralia
-
Kaiser PermanenteOregon Health and Science University; Henry Ford Health SystemCompletedColorectal CancerUnited States
-
University of Colorado, DenverUniversity of MichiganCompletedHPV Vaccination Decision QualityUnited States
-
University of Colorado, DenverUniversity of MichiganCompletedHPV Vaccination StatusUnited States
-
American College of RadiologyThomas Jefferson UniversityActive, not recruitingLung CancerUnited States